跳至主要内容
临床试验/EUCTR2012-000765-20-FI
EUCTR2012-000765-20-FI进行中(未招募)不适用

The Effect of Intravitreal Bevacizumab Injections in Patients with Macular Oedema Caused by AMD, CRVO or DME on the Plasticity of Nerves Studied by Visual Evoked Potentials

Kuopion yliopistollinen sairaala/silmätautien poliklinikka0 个研究点开始时间: 2015年11月20日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All subjects are over 18 years old and subjects in AMD group are over 65 years old. The symptoms of decreased central vision or blurred vision is not allowed to have lasted longer than eigth weeks before entering the study. In CRVO group only non-ischemic subtype is taken into this study.
  • A control group consists healthy subjects over 18 years old without macular oedema.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • - Pregnancy
  • - The eye previously treated with anti-VEGF injections
  • - Opthalmic surgery previously, only cataract surgery wihtout complications is allowed
  • - In AMD and CRVO groups diabetes is exclusion criteria.
  • Anti-VEGF injections or ophtalmic surgery of fellow eye is not an exclusion criteria.

研究者

发起方
Kuopion yliopistollinen sairaala/silmätautien poliklinikka

相似试验